HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Karl Skriner Selected Research

CV07-209

11/2020A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model.
8/2020A SARS-CoV-2 neutralizing antibody protects from lung pathology in a COVID-19 hamster model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Karl Skriner Research Topics

Disease

18Rheumatoid Arthritis
11/2022 - 03/2002
6Arthritis (Polyarthritis)
12/2018 - 03/2005
5Autoimmune Diseases (Autoimmune Disease)
01/2018 - 03/2002
4Systemic Lupus Erythematosus (Libman-Sacks Disease)
05/2011 - 03/2002
3Inflammation (Inflammations)
01/2018 - 03/2005
2COVID-19
11/2020 - 08/2020
2Weight Loss (Weight Reduction)
11/2020 - 08/2020
1Pulmonary Fibrosis (Fibrosing Alveolitis)
11/2022
1Pain (Aches)
01/2021
1Stroke (Strokes)
10/2020
1Acute Coronary Syndrome
10/2020
1Interstitial Lung Diseases (Interstitial Lung Disease)
01/2020
1Lung Diseases (Lung Disease)
01/2020
1Infections
01/2020
1Systemic Scleroderma (Systemic Sclerosis)
08/2009
1Mixed Connective Tissue Disease (MCTD)
02/2008
1Rheumatic Diseases (Rheumatism)
02/2008

Drug/Important Bio-Agent (IBA)

12AutoantibodiesIBA
01/2021 - 03/2002
9AutoantigensIBA
01/2020 - 03/2002
7Proteins (Proteins, Gene)FDA Link
10/2020 - 02/2008
6Anti-Citrullinated Protein AntibodiesIBA
11/2022 - 01/2018
6Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA
01/2021 - 07/2002
5Peptides (Polypeptides)IBA
01/2020 - 12/2005
4EpitopesIBA
11/2020 - 01/2018
4acetyl 4-aminosalicylic acidIBA
10/2020 - 12/2018
3Monoclonal AntibodiesIBA
11/2020 - 01/2019
3AntibodiesIBA
01/2019 - 01/2018
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2008 - 03/2005
2Biomarkers (Surrogate Marker)IBA
01/2021 - 12/2018
2Neutralizing AntibodiesIBA
11/2020 - 08/2020
2CV07-209IBA
11/2020 - 08/2020
2Rheumatoid FactorIBA
10/2020 - 01/2020
2Immunoglobulin M (IgM)IBA
01/2020 - 12/2007
2Nuclear Antigens (Extractable Nuclear Antigens)IBA
01/2018 - 01/2006
2AntigensIBA
05/2011 - 01/2004
2pristane (pristan)IBA
05/2011 - 12/2007
2Immunoglobulin G (IgG)IBA
12/2007 - 12/2005
1Etanercept (Enbrel)FDA Link
01/2021
1omega-Chloroacetophenone (Mace)IBA
10/2020
1cyclic citrullinated peptideIBA
01/2020
16-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA
01/2020
1CitrullineIBA
12/2018
1Antigen-Antibody Complex (Immune Complex)IBA
01/2018
1HLA-DRB1 Chains (HLA DRB1)IBA
01/2018
1hnRNP A2IBA
05/2011
1Nucleic AcidsIBA
05/2011
1Messenger RNA (mRNA)IBA
02/2008
1Mineral Oil (Liquid Paraffin)FDA LinkGeneric
12/2007
1B-Lymphocyte Epitopes (B-Cell Epitope)IBA
12/2005
1Filaggrin ProteinsIBA
07/2002

Therapy/Procedure

1Intradermal Injections
12/2007
1Therapeutics
01/2004